:

Yunfang Wei1, Xianlei Zhao2, Linxia Li1

  • 1Department of Obstetrics & Gynecology, Shanghai Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, People's Republic of China.

ImmunoTargets and therapy
|November 6, 2024
PubMed
概括

这项研究发现,较高水平的炎症蛋白CXCL5与降低子宫内膜异位症的风险有关,这表明CXCL5在这种疾病中起着保护作用.